On March 28, 2024, the Biden administration announced it was finalizing a new rule restricting short-term health plans to a…
Healthcare advocacy groups, including the National Health Law Program, have filed administrative complaints against the Department of Health and Human…
In March 2023, the Biden-Harris Administration released it’s FY2025 budget proposals to broaden healthcare coverage and access; and improve health…
The Florida Senate recently voted to restrict the sale of intoxicating cannabinoid products. SB 1698 addresses health and safety concerns…
On September 29, 2023, the United States District Court for the District of Columbia held that the 2021 NBPP, which…
The FDA recently released updated guidance, titled “Rare Diseases: Considerations for the Development of Drugs and Biological Products,” emphasizing the…
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
A recent study published in the New England Journal of Medicine examined the pricing practices of hospitals participating in the…
The Senate 340B Working Group is soliciting additional stakeholder input on key longstanding issues surrounding the Medicare 340B program. The…
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease: Improving Treatment While Working Toward…